A detailed history of Pnc Financial Services Group, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 11,596 shares of MRVI stock, worth $60,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,596
Previous 11,821 1.9%
Holding current value
$60,531
Previous $84,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$6.84 - $9.73 $1,539 - $2,189
-225 Reduced 1.9%
11,596 $96,000
Q2 2024

Aug 09, 2024

SELL
$6.87 - $11.34 $12,056 - $19,901
-1,755 Reduced 12.93%
11,821 $84,000
Q1 2024

May 10, 2024

BUY
$5.11 - $8.76 $15,703 - $26,919
3,073 Added 29.26%
13,576 $117,000
Q4 2023

Feb 09, 2024

SELL
$4.7 - $9.87 $653 - $1,371
-139 Reduced 1.31%
10,503 $68,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $12,613 - $17,733
1,380 Added 14.9%
10,642 $106,000
Q2 2023

Aug 11, 2023

BUY
$12.09 - $15.0 $5,307 - $6,585
439 Added 4.98%
9,262 $115,000
Q1 2023

May 15, 2023

BUY
$12.99 - $16.48 $21,056 - $26,714
1,621 Added 22.51%
8,823 $123,000
Q4 2022

Feb 10, 2023

BUY
$12.5 - $24.78 $89,262 - $176,953
7,141 Added 11706.56%
7,202 $103,000
Q3 2022

Nov 10, 2022

SELL
$20.6 - $30.37 $226 - $334
-11 Reduced 15.28%
61 $1,000
Q2 2022

Aug 12, 2022

SELL
$26.05 - $37.48 $4,324 - $6,221
-166 Reduced 69.75%
72 $2,000
Q1 2022

May 12, 2022

BUY
$24.46 - $40.92 $3,522 - $5,892
144 Added 153.19%
238 $8,000
Q4 2021

Feb 11, 2022

SELL
$35.0 - $45.94 $3,080 - $4,042
-88 Reduced 48.35%
94 $3,000
Q3 2021

Nov 05, 2021

BUY
$36.8 - $60.62 $2,023 - $3,334
55 Added 43.31%
182 $8,000
Q2 2021

Aug 06, 2021

BUY
$32.46 - $45.0 $4,122 - $5,715
127 New
127 $5,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.